• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏移植后无法恢复正常的微生物组。

A normative microbiome is not restored following kidney transplantation.

机构信息

University of Glasgow, College of Medical, Veterinary and Life Sciences, School of Molecular Biosciences, Davidson Bld, Glasgow, U.K.

Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden.

出版信息

Clin Sci (Lond). 2023 Oct 31;137(20):1563-1575. doi: 10.1042/CS20230779.

DOI:10.1042/CS20230779
PMID:37756543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10582644/
Abstract

Dialysis and kidney transplantation (Ktx) mitigate some of the physiological deficits in chronic kidney disease (CKD), but it remains to be determined if these mitigate microbial dysbiosis and the production of inflammatory microbial metabolites, which contribute significantly to the uraemic phenotype. We have investigated bacterial DNA signatures present in the circulation of CKD patients and those receiving a KTx. Our data are consistent with increasing dysbiosis as CKD progresses, with an accompanying increase in trimethylamine (TMA) producing pathobionts Pseudomonas and Bacillus. Notably, KTx patients displayed a significantly different microbiota compared with CKD5 patients, which surprisingly included further increase in TMA producing Bacillus and loss of salutogenic Lactobacilli. Only two genera (Viellonella and Saccharimonidales) showed significant differences in abundance following KTx that may reflect a reciprocal relationship between TMA producers and utilisers, which supersedes restoration of a normative microbiome. Our metadata analysis confirmed that TMA N-oxide (TMAO) along with one carbon metabolism had significant impact upon both inflammatory burden and the composition of the microbiome. This indicates that these metabolites are key to shaping the uraemic microbiome and might be exploited in the development of dietary intervention strategies to both mitigate the physiological deficits in CKD and enable the restoration of a more salutogenic microbiome.

摘要

透析和肾移植(Ktx)减轻了慢性肾脏病(CKD)的一些生理缺陷,但仍需确定这些方法是否减轻了微生物失调和炎症性微生物代谢产物的产生,这些产物对尿毒症表型有重要贡献。我们研究了存在于 CKD 患者和接受 Ktx 的患者循环中的细菌 DNA 特征。我们的数据与 CKD 进展时的失调增加一致,伴随着产三甲胺(TMA)的机会致病菌假单胞菌和芽孢杆菌的增加。值得注意的是,与 CKD5 患者相比,Ktx 患者的微生物群明显不同,令人惊讶的是,TMA 产生的芽孢杆菌进一步增加,而有益的乳酸杆菌减少。只有两个属(Viellonella 和 Saccharimonidales)在 Ktx 后表现出显著的丰度差异,这可能反映了 TMA 生产者和利用者之间的相互关系,这种关系取代了规范微生物组的恢复。我们的元数据分析证实,三甲胺 N-氧化物(TMAO)和一碳代谢对炎症负担和微生物组的组成都有显著影响。这表明这些代谢物是塑造尿毒症微生物组的关键,可能会被用于开发饮食干预策略,以减轻 CKD 的生理缺陷,并恢复更有益的微生物组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/4e52b254e813/cs-137-cs20230779-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/af1ce21cf46f/cs-137-cs20230779-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/5f38ccc1fe2d/cs-137-cs20230779-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/fbd8f0f9bcd4/cs-137-cs20230779-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/07e5c67091cb/cs-137-cs20230779-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/4e52b254e813/cs-137-cs20230779-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/af1ce21cf46f/cs-137-cs20230779-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/5f38ccc1fe2d/cs-137-cs20230779-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/fbd8f0f9bcd4/cs-137-cs20230779-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/07e5c67091cb/cs-137-cs20230779-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b8/10582644/4e52b254e813/cs-137-cs20230779-g5.jpg

相似文献

1
A normative microbiome is not restored following kidney transplantation.肾脏移植后无法恢复正常的微生物组。
Clin Sci (Lond). 2023 Oct 31;137(20):1563-1575. doi: 10.1042/CS20230779.
2
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.肾功能受损和肠道微生物群落失调导致慢性肾脏病患者中三甲胺-N-氧化物水平升高。
Sci Rep. 2017 May 3;7(1):1445. doi: 10.1038/s41598-017-01387-y.
3
Characterizing the gut microbiota in patients with chronic kidney disease.分析慢性肾脏病患者的肠道微生物群。
Postgrad Med. 2020 Aug;132(6):495-505. doi: 10.1080/00325481.2020.1744335. Epub 2020 Apr 2.
4
Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.靶向抑制肠道微生物三甲胺 N-氧化物生成可减少慢性肾脏病小鼠模型的肾间质纤维化和功能障碍。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1239-1255. doi: 10.1161/ATVBAHA.120.314139. Epub 2020 Mar 26.
5
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.饮食中胆碱的生物利用度与其对肠道微生物组成的关系,及其对人类疾病的调节作用。
Nutrients. 2020 Aug 5;12(8):2340. doi: 10.3390/nu12082340.
6
Gut microbiome in chronic kidney disease.慢性肾脏病中的肠道微生物群
Exp Physiol. 2016 Apr;101(4):471-7. doi: 10.1113/EP085283. Epub 2015 Oct 2.
7
Link between gut microbiota dysbiosis and chronic kidney disease.肠道微生物失调与慢性肾脏病的关系。
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2057-2074. doi: 10.26355/eurrev_202203_28354.
8
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.肠道微生物群的改变及其与慢性肾脏病中炎症因子的相关性。
Front Cell Infect Microbiol. 2019 Jun 12;9:206. doi: 10.3389/fcimb.2019.00206. eCollection 2019.
9
Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.在 CKD 进展过程中,肠道氨基酸代谢紊乱与肠道微生物失调和宏基因组变化有关。
J Pharm Biomed Anal. 2018 Feb 5;149:425-435. doi: 10.1016/j.jpba.2017.11.040. Epub 2017 Nov 15.
10
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential.慢性肾脏病中的肠道微生物组研究:机遇、陷阱和治疗潜力。
Nat Rev Nephrol. 2023 Feb;19(2):87-101. doi: 10.1038/s41581-022-00647-z. Epub 2022 Nov 10.

引用本文的文献

1
Sweet, bloody consumption - what we eat and how it affects vascular ageing, the BBB and kidney health in CKD.甜蜜、血腥的消耗——我们吃的食物如何影响 CKD 患者的血管老化、血脑屏障和肾脏健康。
Gut Microbes. 2024 Jan-Dec;16(1):2341449. doi: 10.1080/19490976.2024.2341449. Epub 2024 Apr 30.

本文引用的文献

1
The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study.三甲胺氮氧化物(TMAO)、CMPF 与晚期慢性肾脏病临床结局的相关性:来自欧洲 QUALity(EQUAL)研究的结果。
Am J Clin Nutr. 2022 Dec 19;116(6):1842-1851. doi: 10.1093/ajcn/nqac278.
2
The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism.微生物 gbu 基因簇将与食用红色肉类相关的心血管疾病风险与微生物组 L-肉碱代谢联系起来。
Nat Microbiol. 2022 Jan;7(1):73-86. doi: 10.1038/s41564-021-01010-x. Epub 2021 Dec 23.
3
The Impact of Enriched Resistant Starch Type-2 Cookies on the Gut Microbiome in Hemodialysis Patients: A Randomized Controlled Trial.
富含抗性淀粉 2 型饼干对血液透析患者肠道微生物组的影响:一项随机对照试验。
Mol Nutr Food Res. 2021 Oct;65(19):e2100374. doi: 10.1002/mnfr.202100374. Epub 2021 Aug 22.
4
Socioeconomic position links circulatory microbiota differences with biological age.社会经济地位将循环微生物群差异与生物年龄联系起来。
Sci Rep. 2021 Jun 16;11(1):12629. doi: 10.1038/s41598-021-92042-0.
5
Related Factors to Streptococcus pneumoniae Invasive Infection and Clinical Manifestations: The Potential Role of Nasopharyngeal Microbiome.肺炎链球菌侵袭性感染的相关因素及临床表现:鼻咽微生物群的潜在作用
Front Med (Lausanne). 2021 Apr 20;8:650271. doi: 10.3389/fmed.2021.650271. eCollection 2021.
6
The Impact of CKD on Uremic Toxins and Gut Microbiota.慢性肾脏病对尿毒症毒素和肠道微生物群的影响。
Toxins (Basel). 2021 Mar 31;13(4):252. doi: 10.3390/toxins13040252.
7
Trimethylamine N-oxide (TMAO) in human health.人体内的氧化三甲胺(TMAO)与健康
EXCLI J. 2021 Feb 11;20:301-319. doi: 10.17179/excli2020-3239. eCollection 2021.
8
Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family.饮食中海藻氨酸通过肠道微生物群驱动 microRNA-378a 家族预防肥胖。
Gut Microbes. 2021 Jan-Dec;13(1):1-19. doi: 10.1080/19490976.2020.1862612.
9
Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats.霉酚酸介导的自发性高血压大鼠肠道微生物群重塑和肠道-大脑轴改善。
Biomed Pharmacother. 2021 Mar;135:111189. doi: 10.1016/j.biopha.2020.111189. Epub 2020 Dec 31.
10
Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?肠道微生物群衍生的氧化三甲胺:膳食脂肪酸与心血管疾病之间的桥梁?
Food Res Int. 2020 Dec;138(Pt B):109812. doi: 10.1016/j.foodres.2020.109812. Epub 2020 Oct 21.